致病性α1-抗素聚合在人类肝脏中的机制
Ibrahim Aldobiyan1,2, Emma L K Elliston1, Narinder Heyer-Chauhan1
1UCL Respiratory, Division of Medicine and the Institute of Structural and Molecular Biology, University College London, London WC1E 6JF, United Kingdom.
概括
这种SERPINA1 Z变体会导致严重的α-1抗素缺乏和肝脏疾病. 它在人肝中的聚合物结构揭示了错误折叠如何导致疾病,为新疗法提供了目标.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 遗传学 是一个遗传学.
背景情况:
- 起源于斯堪的纳维亚的SERPINA1 Z基因基因 (Glu342Lys) 影响高达2.5%的北欧人.
- 这种等位基因对95%的严重α-1抗素缺乏病例负责.
- 这种Z变体自组合成聚合物,这些聚合物沉积在肝细胞中,导致肝脏疾病.
研究的目的:
- 直接从人类肝脏组织中确定α-1抗素聚合物的子单元结构.
- 在体内阐明聚合物形成的分子机制.
- 为了确定与α-1抗素缺乏相关的肝病的潜在治疗点.
主要方法:
- 低温电子显微镜被用来确定从人类肝脏中分离的高分子的4.0Å亚单元结构.
- 使用抗体Fab域和专门的样本准备策略来克服技术挑战.
- 分析了聚合物的结构,以了解体内聚合过程.
主要成果:
- 该结构显示,聚合物形成涉及反应性中心循环作为β-链插入到中央β-片中.
- 在聚合过程中,C端区域被移动并纳入下一个子单元.
- 这种很好的折叠结构部分模仿了本地蛋白质构造,与典型的粉样蛋白聚合不同.
结论:
- 确定的结构提供了关于α-1抗素聚合物的稳定性和链形成倾向的见解.
- 在体内了解聚合机制对于开发疗法至关重要.
- 这些发现支持小分子有潜力抑制聚合并治疗与α-1抗素缺乏相关的肝病.
相关概念视频
Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
Amyloid Fibrils
6.3K
6.3K
ATP Synthase: Mechanism
16.6K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
16.6K
Allosteric Proteins-ATCase
6.4K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.4K


